From October 1, 2021 to December 31, 2021, the company has repurchased 89,238 shares, representing 0.23% for $41.3 million. With this, the company has completed the repurchase of 3,473,730 shares, representing 9.07% for $336.56 million under the buyback announced on November 14, 2007.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
62.8 USD | +1.09% | -4.15% | -18.61% |
Apr. 18 | Deutsche Bank Adjusts Bio-Techne Price Target to $82 From $85 | MT |
Apr. 08 | RBC Raises Price Target on Bio-Techne to $79 From $75, Keeps Sector Perform Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.61% | 9.87B | |
-0.02% | 42.11B | |
+48.60% | 40.08B | |
+5.04% | 40B | |
-11.32% | 26.87B | |
+5.25% | 24.58B | |
-23.83% | 18.44B | |
-1.62% | 11.94B | |
+22.75% | 11.66B | |
+6.44% | 11.01B |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- Tranche Update on Bio-Techne Corporation's Equity Buyback Plan announced on November 14, 2007.